目錄:MedChemExpress LLC>>生化試劑>> Atuveciclib S-Enantiomer | MCE
CAS | 2250279-81-1 | 純度 | 99.38% |
---|---|---|---|
分子量 | 387.43 | 分子式 | C??H??FN?O?S |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-12871C | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥/生物制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 2250279-81-1
產(chǎn)品活性:Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is a potent and selective CDK9 inhibitor, which inhibits CDK9/CycT1 with an IC50 of 16 nM.
研究領(lǐng)域:Cell Cycle/DNA Damage
作用靶點:CDK
In Vitro: In comparison with Atuveciclib (BAY-1143572), Atuveciclib (BAY-1143572) S-Enantiomer reveals very similar in vitro properties, well within the limits of measurement accuracy; however, with multiple batches of Atuveciclib (BAY-1143572) S-Enantiomer there is a trend toward a slightly lower activity against CDK9 in the biochemical assay (IC50 CDK9/CycT1: 16 nM) and antiproliferative activity against HeLa cells (IC50: 1100 nM) .
In Vivo: Atuveciclib (BAY-1143572) S-Enantiomer exhibits blood/plasma ratios of about 1. Relative to Atuveciclib (BAY-1143572), Atuveciclib (BAY-1143572) S-Enantiomer reveals very similar rat PK properties in vivo (CLb: 1.2 L/kg per hour, Vss: 1.2 L/kg, t1/2: 0.6 h, F: 53?%).
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Anti-Breast Cancer Compound Library | Anti-Blood Cancer Compound Library | Cancer Stem Cells Compound Library | Membrane Protein-targeted Compound Library | SY-5609 | CLK1/2-IN-1 | SB-218078 | Toyocamycin | (S)-LY3177833 hydrate | Dinaciclib | EGFR/HER2/CDK9-IN-2 | CDK8-IN-11 | SNS-032 | M2N12 | Palbociclib-d8 | EGFR/CDK2-IN-1 | BSJ-04-132 | (E/Z)-Zotiraciclib | CCT-251921 | BS-181 | Ribociclib-d8 | CDK9-IN-9 | Flavopiridol | SRI-29329 | dCeMM4 | GSK 3 Inhibitor IX | CDK9-IN-7 | BSJ-03-204 | Amantadine-d6 | K00546 | Abemaciclib metabolite M18 hydrochloride | Ribociclib-d6 | Lacto-N-fucopentaose I | CDK2/4/6-IN-2
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,常用試劑盒 ,,更有 PROTAC,、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項目,;
• 提供虛擬篩選,離子通道篩選,,代謝組學(xué)分析檢測分析,,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控,、驗證體系,;
• 提供 LC/MS、NMR,、HPLC,、手性分析、元素分析等各項質(zhì)檢報告,,確保產(chǎn)品的高純度,、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤新的制藥及生命科學(xué)研究進展,,為您提供*新的活性化合物;
• 與世界各大制藥公司及*科研機構(gòu)建立了長期的合作,。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)